Document is current
Any future updates will be listed below
-
Authors
Kempf, Nicolas
Körber, Rainer
Plaumann, Markus
Pravdivtsev, Andrey N.
Engelmann, Jörn
Boldt, Johannes
Scheffler, Klaus
Theis, Thomas
Buckenmaier, Kai
-
Funding
Funding for this research was provided by:
German Research Foundation (BU 2694/6-1)
German Research Foundation (BU 2694/6-1)
German Research Foundation (PL 576/6-1)
German Research Foundation (PR 1868/3-1)
German Research Foundation (BU 2694/6-1)
German Federal Ministry of Education and Research (BMBF) within the framework of the e:Med research and funding concept (01ZX1915C)
Open Access Publikationsfonds Schleswig-Holstein
European Regional Development Fund
Zukunftsprogramm Wirtschaft Schleswig Holstein (122-09-053)
Humboldt Foundation, Friedrich Wilhelm Bessel Award (Humboldt ID 1197893)
Max Planck Institute for Biological Cybernetics
- License Information
-
More Information
Article History
Received: 28 November 2023
Accepted: 16 February 2024
First Online: 23 February 2024
Competing interests
: TT is a co-founders and equity holder of Vizma Life Sciences (VLS). The terms of TT's arrangement have been reviewed and approved by NC State University in accordance with its policy on objectivity in research.
